Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (8): 863-868.
DOI: 10.19803/j.1672-8629.20250272

Previous Articles     Next Articles

Doxorubicin-Induced Cardiotoxicity Related to Regulation of Mitochondrial-Associated Membranes by PDK4

SHI Yanlei1,2, ZHANG Bing3,4, WANG Yu2, XU Zhuoxin1,2, TIAN Min2, MENG Min2*, SA Rina2,3#   

  1. 1School of Pharmacy, Gansu University of Chinese Medicine, Lanzhou Gansu 730000, China;
    2Department of Pharmacy, Gansu Provincial Hospital, Lanzhou Gansu 730000, China;
    3Zhang Bing’s Studio of Qi-Huang Scholars, Gansu Provincial Hospital, Lanzhou Gansu 730000, China;
    4School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102400, China
  • Received:2025-04-29 Online:2025-08-15 Published:2025-08-13

Abstract: Objective To analyze the molecular mechanism through which PDK4 regulates Mitochondria-Associated Membranes(MAMs) and explore its potential association with anthracycline-induced cardiotoxicity in order to provide data for developing cardioprotective strategies. Methods By reviewing recent literature, the role of PDK4 in MAMs and its potential involvement in anthracycline-induced cardiotoxicity was explored. Results There were complicated interactions between PDK4, MAMs, and anthracycline-induced cardiotoxicity, primarily manifested as energy metabolism disorders, oxidative stress, apoptosis, and calcium homeostasis imbalance. These interactions played a significant role in the progression of anthracycline-induced cardiotoxicity. Conclusion Overexpression of PDK4 can, above all, disrupt calcium homeostasis mediated by MAMs, leading to mitochondrial calcium overload and consequently exacerbating anthracycline-induced cardiotoxicity. This study can offer novel insights and help identify potential therapeutic targets for developing protective strategies against anthracycline-associated cardiotoxicity.

Key words: Anthracyclines, PDK4, Cardiotoxicity, Mitoch-ondria-Associated Membranes(MAMS), Mitochondrial Dysfunction, Calcium Homeostasis

CLC Number: